| Literature DB >> 24040388 |
Tina M Blackmore1, Alex Dugdale, Caroline McG Argo, Gemma Curtis, Eric Pinloche, Pat A Harris, Hilary J Worgan, Susan E Girdwood, Kirsty Dougal, C Jamie Newbold, Neil R McEwan.
Abstract
The horse, as a hindgut fermenter, is reliant on its intestinal bacterial population for efficient diet utilisation. However, sudden disturbance of this population can result in severe colic or laminitis, both of which may require euthanasia. This study therefore aimed to determine the temporal stability of the bacterial population of faecal samples from six ponies maintained on a formulated high fibre diet. Bacterial 16S rRNA terminal restriction fragment length polymorphism (TRFLP) analyses of 10 faecal samples collected from 6 ponies at regular intervals over 72 hour trial periods identified a significant pony-specific profile (P<0.001) with strong stability. Within each pony, a significantly different population was found after 11 weeks on the same diet (P<0.001) and with greater intra-individual similarity. Total short chain fatty acid (SCFA) concentration increased in all ponies, but other changes (such as bacterial population diversity measures, individual major SCFA concentration) were significant and dependent on the individual. This study is the first to report the extent of stability of microbes resident in the intestinal tract as represented with such depth and frequency of faecal sampling. In doing so, this provides a baseline from which future trials can be planned and the extent to which results may be interpreted.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24040388 PMCID: PMC3770578 DOI: 10.1371/journal.pone.0075079
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Dendrogram of Hamming Distances (binary abundance) from TRFLP data.
10 samples per pony (n = 6) per trial period (1, 2) are represented. Dendrogram coloured by pony and samples clustering by pony and trial period are labelled (eg P1,TP1 represents pony 1 in TP1). i, ii denote first and second clusters within pony and trial period.
Figure 2Dendrogram of Manhattan Distances (relative abundance) from TRFLP data.
10 samples per pony (n = 6) per trial period (1, 2) are represented. Dendrogram coloured by pony and samples clustering by pony and trial period are labelled (eg P1,TP1 represents pony 1 in TP1). i, ii denote first and second clusters within pony and trial period.
Figure 3Principal component analysis plot for binary data.
Split of data from trial period (TP) 1 to TP2 observed on PC1. Each pony denoted by different colour. TP1 marked by circles, TP2 by triangles.
Bacterial population diversity indicators: number of TRF, Shannon Diversity Indices and Evenness.
| No. of TRF | Shannon Diversity Indices | Shannon Equitability | ||||||||||||||
| Pony | TP1 | TP2 | P1 | TP1 | TP2 | P1 | TP1 | TP2 | P1 | |||||||
| Mean | SE | Mean | SE | Mean | SE | Mean | SE | Mean | SE | Mean | SE | |||||
| MspI | 1 | 22.2a | 0.98 | 22.6 b | 0.99 | ns | 2.81 ab | 0.037 | 2.81 b | 0.048 | ns | 0.910b | 0.0035 | 0.905ab | 0.0047 | ns |
| 2 | 23.4 ab | 0.56 | 18.6 ab | 1.37 | ** | 2.87 abc | 0.022 | 2.60 ab | 0.065 | *** | 0.910 b | 0.0028 | 0.895a | 0.0031 | ** | |
| 3 | 24.8 ab | 2.00 | 17.2 a | 1.49 | ** | 2.94 bc | 0.059 | 2.50 a | 0.110 | ** | 0.925 b | 0.0054 | 0.892a | 0.0104 | * | |
| 4 | 22.0 a | 1.10 | 20.9 ab | 0.99 | ns | 2.73 a | 0.053 | 2.74 ab | 0.044 | ns | 0.887 a | 0.0041 | 0.904ab | 0.0031 | ** | |
| 5 | 20.0 a | 0.82 | 21.2 ab | 0.59 | ns | 2.71 a | 0.034 | 2.81 b | 0.028 | * | 0.907 b | 0.0045 | 0.921b | 0.0026 | * | |
| 6 | 27.8 b | 1.53 | 21.3 ab | 0.88 | ** | 3.02 c | 0.050 | 2.78 b | 0.034 | ** | 0.911 b | 0.0037 | 0.911ab | 0.0025 | ns | |
| P2 value | ** | * | *** | ** | *** | ** | ||||||||||
| ScrFI | 1 | 13.5 b | 0.72 | 11.0 ab | 0.95 | ns | 2.15 b | 0.066 | 1.82 a | 0.077 | ** | 0.828 c | 0.0102 | 0.768a | 0.0074 | *** |
| 2 | 11.6 ab | 0.70 | 14.8 c | 0.33 | ** | 1.87 ab | 0.048 | 2.31 bc | 0.012 | *** | 0.768 ab | 0.0093 | 0.858c | 0.0031 | *** | |
| 3 | 9.3 a | 0.78 | 10.6 ab | 0.93 | ns | 1.72 a | 0.098 | 1.95 ab | 0.089 | ns | 0.779 abc | 0.0226 | 0.847c | 0.0191 | * | |
| 4 | 11.2 ab | 0.59 | 13.3 bc | 0.84 | ns | 1.99 ab | 0.064 | 2.16 bc | 0.073 | ns | 0.827 bc | 0.0082 | 0.840bc | 0.0082 | ns | |
| 5 | 11.2 ab | 0.77 | 9.5 a | 0.79 | ns | 1.96 ab | 0.086 | 1.74 a | 0.066 | * | 0.820 bc | 0.0171 | 0.791ab | 0.0179 | ns | |
| 6 | 9.9 a | 0.54 | 13.4 bc | 0.87 | ** | 1.69 a | 0.042 | 2.01 abc | 0.07 | ** | 0.743 a | 0.0089 | 0.776a | 0.0124 | * | |
| P2 value | ** | *** | *** | *** | *** | *** | ||||||||||
| HaeIII | 1 | 17.5 a | 0.76 | 17.9 | 1.35 | ns | 2.49 a | 0.053 | 2.53 b | 0.079 | ns | 0.871 a | 0.0073 | 0.886b | 0.0070 | ns |
| 2 | 23.1 a | 1.18 | 12.7 | 1.65 | *** | 2.80 b | 0.049 | 2.07 a | 0.127 | *** | 0.895 ab | 0.0043 | 0.831a | 0.0155 | *** | |
| 3 | 19.6 a | 1.02 | 15.3 | 0.87 | ** | 2.62 ab | 0.053 | 2.36 ab | 0.063 | ** | 0.885 a | 0.0048 | 0.868ab | 0.0062 | * | |
| 4 | 29.1 b | 1.74 | 18.3 | 0.83 | *** | 3.08 c | 0.052 | 2.61 b | 0.047 | *** | 0.919 bc | 0.0036 | 0.900b | 0.0037 | ** | |
| 5 | 23.0 a | 1.51 | 17.4 | 1.90 | * | 2.87 bc | 0.061 | 2.45 ab | 0.112 | ** | 0.922 c | 0.0049 | 0.874b | 0.0081 | *** | |
| 6 | 22.0 a | 1.60 | 17.4 | 1.38 | * | 2.71 ab | 0.082 | 2.46 ab | 0.089 | ns | 0.882 a | 0.0085 | 0.865ab | 0.0107 | ns | |
| P2 value | *** | ns | *** | ** | *** | *** | ||||||||||
Average and standard error (SE) for each pony within trial period and for each restriction enzyme shown. P1 values identify significant changes between TP within pony and RE. P2 values identify significant differences between ponies, within TP and RE. ns – not significant, * P<0.05; ** P<0.01; *** P<0.001.
Concentration (mM) of total and each major SCFA, for each pony and trial period.
| Pony | 1 | 2 | 3 | 4 | 5 | 6 | P2 value | ||
| Total SCFA | TP1 | Mean | 96.01ab | 72.57bc | 105.71a | 62.13c | 72.27bc | 76.18abc | ** |
| SE | 7.950 | 5.473 | 6.428 | 6.413 | 6.132 | 8.818 | |||
| TP2 | Mean | 93.38 | 99.68 | 107.08 | 78.78 | 99.86 | 104.71 | ns | |
| SE | 9.719 | 6.453 | 7.295 | 4.757 | 6.867 | 7.627 | |||
| P1 value | ns | ** | ns | ns | ** | * | |||
| Acetate | TP1 | Mean | 77.85ab | 58.58bc | 84.43a | 51.04c | 56.39bc | 61.35abc | *** |
| SE | 6.718 | 4.339 | 5.098 | 5.592 | 4.875 | 6.982 | |||
| TP2 | Mean | 75.96 | 79.86 | 86.84 | 66.57 | 83.52 | 85.24 | ns | |
| SE | 7.352 | 5.246 | 6.428 | 4.649 | 5.564 | 6.622 | |||
| P1 value | ns | ** | Ns | * | ** | * | |||
| Propionate | TP1 | Mean | 13.40 a | 9.79 ab | 13.11 a | 8.24 b | 10.70 ab | 9.33 ab | ** |
| SE | 1.031 | 0.792 | 0.865 | 0.696 | 1.241 | 1.387 | |||
| TP2 | Mean | 11.03 ab | 15.34 a | 12.86 ab | 8.48 b | 10.59 ab | 12.67 ab | *** | |
| SE | 1.862 | 1.096 | 0.799 | 0.553 | 0.983 | 0.673 | |||
| P1 value | ns | *** | ns | ns | ns | * | |||
| Butyrate | TP1 | Mean | 4.06 b | 3.44 b | 5.99 a | 2.67 b | 3.96 b | 4.12 b | *** |
| SE | 0.327 | 0.322 | 0.424 | 0.186 | 0.346 | 0.576 | |||
| TP2 | Mean | 4.98 ab | 3.86 ab | 5.67 a | 3.10 b | 4.28 ab | 5.47 a | ** | |
| SE | 0.69 | 0.284 | 0.418 | 0.214 | 0.614 | 0.493 | |||
| P1 value | ns | ns | ns | ns | ns | * | |||
| Valerate | TP1 | Mean | 0.70 cd | 0.76 cd | 2.18 a | 0.18 d | 1.22 bc | 1.39 b | *** |
| SE | 0.103 | 0.119 | 0.157 | 0.097 | 0.156 | 0.243 | |||
| TP2 | Mean | 1.41 ab | 0.62 b | 1.72 a | 0.63 b | 1.47 ab | 1.32 ab | ** | |
| SE | 0.306 | 0.078 | 0.14 | 0.091 | 0.378 | 0.294 | |||
| P1 value | * | ns | * | ** | ns | ns | |||
P1 values identify significant changes between TP within pony and each SCFA. P2 values identify significant differences between ponies, within TP and each SCFA. ns – not significant, * P<0.05; ** P<0.01; *** P<0.001.
Figure 4Cross validated discriminant function analysis plot for relative FTIR data by pony (both trial periods).
Trained data used in the original validation process are denoted by a cross, whilst test data are denoted by a star. Between the two DF values 99.66% of the total variance was described.